Development and validation of the migraine-specific quality of life questionnaire

Headache

Volumn 38, Issue 4, 1998, Pages 295-302

  Jhingran, Priti ^a   Osterhaus, Jane T ^a   Miller, David W ^a   Lee, Jeffrey T ^b   Kirchdoerfer, Leonard ^c  

^a GLAXOSMITHKLINE   (United States)

^b Advanced Health Outcomes Inc   (United States)

^c GENENTECH INC   (United States)

Author keywords

Health related quality of life; Migraine; Migraine Specific Quality of Life Questionnaire; MSQ; Psychometric analysis; Quality of life

Indexed keywords

ADULT; ARTICLE; DAILY LIFE ACTIVITY; FEMALE; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE;

EID: 0031899826     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1998.3804295.x     Document Type: Article

References (24)

1. Ries PW. Current estimates from the National Health Interview Survey: United States, 1984. National Center for Health Statistics; 1986, Vital & Health Statistics-Series 10 No. 156 US Depart of Health and Human Services publication (PHS) 86-1584.
2. Clouse JC, Osterhaus JT. Healthcare resource use and costs associated with migraine in a managed healthcare setting. Ann Pharmacother. 1994;28:659-664.
3. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69.
4. Osterhaus JT, Townsend RJ, Gandek B, Ware JE Jr. Measuring the functional status and well-being of patients with migraine headache. Headache. 1994;34:337-343.
5. Solomon GD, Skobieranda FG, Gragg LA. Quality of life and well-being of headache patients: measurement by the medical outcomes study instrument. Headache. 1993;33:351-358.
6. Osterhaus JT, Gutterman DL, Plachetka JR. Health care resource and lost labor costs of migraine headache in the U.S. Pharmacoeconomics. 1992;2:67-76.
7. Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the National Health Interview Survey. Headache. 1993;33:29-35.
8. Solomon GD, Skobieranda FG, Genzen JR. Quality of life assessment among migraine patients treated with sumatriptan. Headache. 1995;35:449-454.
9. Ware JE. SF-36© Health Survey Manual & Interpretation Guide. Boston, Mass: The Health Institute, New England Medical Center; 1993.
10. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
11. Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. Can Med Assoc J. 1986;134:889-895.
12. Guyatt GH, Feeny DH, Patrick DL. Measuring healthrelated quality of life. Ann Intern Med. 1993;118:622-629.
13. Jaeschke R, Guyatt GH. How to develop and validate a new quality of life instrument. In: Spilker B, ed. Quality of Life Assessment in Clinical Trials. New York: Raven Press; 1991.
14. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47:76-83.
15. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
16. Kim J, Mueller CW. Introduction To Factor Analysis. What Is It and How To Do It. Sage University Paper Series on Quantitative Applications in the Social Sciences; Beverly Hills, Calif: Sage Publications; 1978:7-13.
17. Campbell DT, Fiske DW. Convergent and discriminant validation by the Multitrait-Multimethod Matrix. Psychol Bull. 1959;2:81-105.
18. Bernstein and Nunnally J. Psychometric Theory. 3rd ed. New York: McGraw Hill; 1994.
19. Helmstadter GC, Cliffs NJ. Principles of Psychological Measurement. England: Prentice Hall; 1964.
20. Hays RD, Hayaschi T, Carson S, Ware JE. User's Guide for the Multi-trait Analysis Program (MAP) Rand Note #N-27860-RC.
21. Payers PM, Jones DR. Measuring and analysing quality of life in cancer clinical trials: a review. Star Med. 1983;2:429-446.
22. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273:59-65.
23. Jhingran P, Cady RK, Rubino J, Miller D, Grice RB, Gutterman DL. Improvements in health-related quality of life with sumatriptan treatment for migraine. J Fam Pract. 1996;42:36-42.
24. Cohen JA, Beall DG, Miller DW, Beck A, Pait DG, Clements BD. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences. Fam Med. 1996;28:171-177.